Bartz, René <br/><br/>
Preclinical Development of U3-1784, a Novel FGFR4 Antibody Against Cancer, and Avoidance of Its On-target Toxicity.  [electronic resource] 

 -  Molecular cancer therapeutics  10 2019 
 - 1832-1843 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-18-0048  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cholestyramine Resin--pharmacology<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Ileum--drug effects<br/>Liver--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>NIH 3T3 Cells<br/>Receptor, Fibroblast Growth Factor, Type 4--immunology<br/>Signal Transduction--drug effects<br/>Sorafenib--pharmacology